Blog

  • Italy find their spark in rising star Saliou Niang

    Italy find their spark in rising star Saliou Niang

    The official EuroBasket app

    LIMASSOL (Cyprus) – When Gianmarco Pozzecco was formulating his plan for FIBA EuroBasket 2025 early on this summer, the Italy national team head coach didn’t know exactly what to expect from Saliou Niang.

    Let’s just say that they 21-year-old talent has blown away any expectations Pozzecco had for him. And Niang’s Italian teammates have been similarily surprised.

    Niang has come out of the gates on fire in Limassol as Italy’s leading scorer through two games with 13.0 points to go with 2.5 rebounds. He shined so brightly in Italy’s win over Georgia, that his 15-point performance – which included eight points in the game-deciding 16-0 run – earned him the TCL Player of the Game honor.

    “Maybe I didn’t imagine I’d have this impact from the start. But even in practice, I was able to immediately get along well with my teammates, and I’m happy with how I’m playing and what I am able to give the team, and I’ll try to do that in every game,” said Niang, who is playing his first major competition.

    Niang also became the first Italian player under 22 year to have scored 10+ points in multiple EuroBasket games since Alessandro Gentile in 2013.

    Saliou Niang in his Italy debut against Hungary in the EuroBasket Qualifiers

    EuroBasket 2025 is just about Niang’s debut with the senior national team.

    He was with the team for the final window of the FIBA EuroBasket 2025 Qualifiers in February 2025. He played 11 minutes in the final qualifying game and picked up 3 rebounds.

    Niang since then has had a whirlwind ride. He took off after the window back with his club Trento and averaged 10.1 points over the final 15 games of the year after having scored in double figures just once the whole season. He also averaged 5.3 rebounds with a new-found confidence.

    That resulted in Niang getting selected by the Cleveland Cavaliers in the second round of the NBA Draft in June 2025. And he played for Cleveland in the NBA Summer League.

    “The Summer League helped me a lot to be ready for here. When I go to the court I just do my thing and thinkg how I can help the team: give energy, try to control the defensive rebounds. The simple things that can help the team,” said Niang, who was born in Senegal but came to Italy with his parents when he was 2 years old.

    Niang, who will play for Italian powerhouse Virtus Bologna next season, came to the Italy camp and opened eyes right from the start.

    “I’m not surprised by him any more. He’s been amazing the whole summer.”

    Simone Fontecchio about Saliou Niang

    “I didn’t know him personally before this summer because I never got to play with him, but he definitely surprised me from the first days of training camp,” Italy’s star forward Simone Fontecchio said before the tournament.

    “His level of athleticism is crazy. I don’t think we’ve ever seen anything like it in Italian guys in the last few years. So it definitely helped us and it’s a huge help with high energy and intensity for the second unit.”

    After Niang’s showing against Georgia, Fontecchio offered: “I’m not surprised by him any more. He’s been amazing the whole summer. He can only get better and the sky is the limit for him.”

    Matteo Spagnolo raved about Niang’s freak athleticism but said there is plenty more to come for him.

    “I feel like his role will be bigger and bigger every year, and for sure he could be the main guy or one of the main guys on the team when the time come,” Spagnolo said.

    “His impact already now is something that we can already use and we will continue to use.”

    Gianmarco Pozzecco about Saliou Niang

    Pozzecco meanwhile couldn’t refrain from cracking a giant smile, big laugh and endearing glance with Niang at the Georgia post-game press conference when asked about his young talent.

    “He surprised me. He surprised the whole world. We knew that he could be good and we knew that he could have a future, a big future in front of him. His impact already now is something that we can already use and we will continue to use,” Pozzecco said.

    Saliou Niang has been a massive boost to Italy’s chances

    Saliou Niang has been a massive boost to Italy’s chances

    Saliou Niang has been a massive boost to Italy’s chances

    Saliou Niang has been a massive boost to Italy’s chances

    Saliou Niang has been a massive boost to Italy’s chances

    Saliou Niang has been a massive boost to Italy’s chances

    Saliou Niang has been a massive boost to Italy’s chances

    Saliou Niang has been a massive boost to Italy’s chances

    Saliou Niang has been a massive boost to Italy’s chances

    The head coach preaches family in his team and he emphasized how telling it is that Niang has already been so expected in the group.

    “Veterans really help him, but to help teammates you have to love them. To love young guys they have to deserve it. In this business, the main business is to love each other. If you are young, you have to earn that kind of love from the veterans. it’s working good. The veterans want to help him,” Pozzecco said.

    Niang is showing a maturity level beyond his years and has really been a major help to Italy. And no one else needs to be surprised any more.

    Read more about the Italian team and Group C

    FIBA EuroBasket 2025 Preview: Italy

    Group C: Who is playing FIBA EuroBasket 2025 in Limassol?

    FIBA

    Continue Reading

  • When hospitals become HIV vectors

    When hospitals become HIV vectors

    PUBLISHED
    August 31, 2025

    Whether for a minor injury or a life-saving procedure, hospitals are where sick people rush to in the hopes of getting better. However, when proper infection control protocols are not followed, a patient walking in for a simple blood test might leave the hospital unknowingly carrying HIV-AIDS.

    According to the Better Health Channel, basic infection control protocols for HIV-AIDS at hospitals involve the disposal of single-use syringes in approved sharps containers, decontamination and sterilization of reusable medical devices after each use, disposal of single use medical devices, provision of personal protective equipment (PPE) gowns, gloves and eyewear for healthcare workers, and cleaning of spilled body fluids and laundry as per strict guidelines.

    Although hospital officials in Pakistan assure the presence of infection control departments at government hospitals, in reality, these bodies remain non-functional and adherence to standard operating procedures (SOPs) is highly unsatisfactory. The human immunodeficiency virus (HIV) living in the bloodstream is easily transmitted through contact with an infected person’s bodily fluids, which could be present on unsterilized medical apparatus and work surfaces. Pakistan’s lack of an effective strategy to prevent diseases is one reason why the number of HIV-AIDS patients, currently around 290,000, continues to grow.

    A patient’s family at the Civil Hospital’s Infection Unit revealed that their brother, diagnosed with HIV in 2020, fled the hospital due to unhygienic conditions. After persuasion, the family got him re-registered at the Lyari General Hospital, where he now receives monthly medication. “The appalling condition of hygiene at public hospitals worsens the patient’s mental and physical health, burdening their families. Medical neglect and lack of sanitation are major contributors to the spread of infections in these healthcare facilities,” claimed the family.

    Similarly, Asghar, whose elder brother acquired HIV-AIDS during the 2023 outbreak, recounted his family’s tough journey. “My completely healthy brother used to work as a lab technician at a large private hospital in Karachi. Suddenly, his health started deteriorating and it was revealed that he had contracted HIV. Once his treatment started, my brother had to quit his job,” shared Asghar.

    Dr Pir Ghulam Nabi Shah Jilani, Deputy Director at the Karachi Health Department, claimed that infection prevention committees were functional in government hospitals. “These committees, comprising qualified doctors and pathologists, are tasked with ensuring sterilization and proper disposal of medical waste. However, their effectiveness remains questionable,” noted Dr Jilani, while speaking of Sindh, where HIV transmission has increased by 139.6 per cent over the past five years, with 1,438 cases reported in 2020 and 3,446 cases recorded in 2024.

    Professor Dr Faisal Mahmood, an infectious disease specialist at the Aga Khan University Hospital, emphasized the urgent need to implement infection control protocols at hospitals and clinics. “Patients can be carriers, and hospitals must treat every patient as potentially infectious,” said Dr Mahmood, while mentioning medical protocols, which were clearly ignored in Punjab, where healthcare facilities’ lamentable adherence to infection control dragged multiple patients towards sickness and death.

    Macintosh HD:Users:ZeeshanAhmad:Desktop:Magazine:Stories:HIV Graph 2.png

    In October 2024, over 24 nephrology patients acquired the HIV virus at the Nishtar Hospital in Multan, which is the largest facility offering dialysis to over 200 registered patients from South Punjab. During the investigation, it was revealed that a patient with HIV was dialyzed without proper sterilization protocols, which led to the spread of the virus to other patients due to the negligence of hospital staff.

    Sources revealed that inspections of other government hospitals also found similar lapses in infection control protocols for HIV. Health Minister Salman Rafiq handed the matter over to the Punjab Healthcare Commission for further investigation. However, doctors at the Nishtar Hospital did not cooperate, and when summoned to the Lahore office, they presented excuses and resisted.

    When contacted, the Punjab Healthcare Commission declined to provide further details on the grounds that it was investigating the matter and monitoring adherence to infection control SOPs. Dr Zahid Ansari, former Head of the Sindh Blood Transfusion Authority, clarified the difference between HIV-positive individuals and AIDS patients.

    “HIV-positive individuals should not donate blood, and their used medical tools like syringes or razors must not be reused. The virus can be identified through specific blood tests and viral load analysis. Four key diseases — HIV, Hepatitis B, Hepatitis C, and malaria — must be screened in blood tests before transfusions,” emphasized Dr Ansari.

    In the Nishtar Hospital incident, it was clear that screening procedures were completely ignored. Despite the gravity of the situation, the issue has once again disappeared into the background in Punjab, where more than 7,000 HIV cases were reported last year.

    Shehzad, a 60-year-old dialysis patient at the Jinnah Hospital in Lahore, conveyed his worries after the Multan hospital outbreak. “After hearing about what happened at the Nishtar Hospital, I live in fear. Even routine procedures now feel dangerous. Patients are constantly worried that they may contract a serious illness at any time due to medical negligence,” revealed Shehzad.

    Similar concerns have mounted over the poor performance of the Infection Prevention Committee and the Healthcare Commission in Khyber-Pakhtunkhwa, which has observed an 888.1 per cent increase in the incidence of HIV-AIDS over the past three years, with 816 cases reported in 2022, 5,543 cases reported in 2023, and an alarming 8,063 cases recorded in 2024.

    Major medical teaching institutions (MTIs) in Peshawar, including the Lady Reading Hospital, Khyber Teaching Hospital, and Hayatabad Medical Complex, along with district-level Tehsil Headquarter Hospitals (THQs) are failing to maintain effective infection control and sterilization systems. Instead of preventing diseases, these hospitals are allegedly turning into hotbeds of infectious outbreaks.

    A technician at the Hayatabad Medical Complex, speaking on the condition of anonymity, revealed that standard operating procedures (SOPs) for infection control were not being followed at all. “We have repeatedly requested the administration to provide basic supplies for infection control. However, now we do not even have spirit or syringes available, let alone anything else for infection prevention,” informed the technician.

    Dr Amir Taj, an infection control expert, told The Express Tribune that it was unfortunate that both the Infection Control Committee and the Healthcare Commission, which were created for the very purpose of controlling the spread of transmissible infections, were failing to do their job.

    “Instead of controlling infections, the Healthcare Commission seems more focused on collecting hospital fees and registration charges. Infections like HIV, Hepatitis, and others are rapidly spreading, costing the government billions of rupees each year. If proper infection control systems were in place at hospitals, patients would recover faster, and the national treasury would also benefit,” opined Dr Taj.

    On the other hand, Dr Tariq Hayat, Director of the HIV Control Programme, stated that SOPs for infection control were strictly followed at HIV and Hepatitis control centers operating within hospitals. However, he also acknowledged the fact that awareness sessions on infection control were urgently needed at both public and private hospitals.

    Dr Muhammad Naeem, former Director of the Sindh AIDS Control Program, recalled that Larkana faced major HIV outbreaks in 2019 and 2023. “After the Rato Dero outbreak, the Sindh Health Department screened 37,272 people in Larkana. HIV-AIDS was confirmed in 1,811 cases. Contributing factors included reused syringes, abundance of unqualified healthcare providers and unregulated blood transfusion practices,” revealed Dr Naeem.

    Speaking to the Express Tribune on the matter, Azam Rehman, spokesperson for the Healthcare Commission, claimed that the commission strictly enforced SOPs for infection control, fining both private and public hospitals found violating the guidelines.

    Despite official claims, the current poor adherence to infection control protocols at hospitals across the country demands urgent government intervention, including strict regulation of medical practices, enforcement of hygiene protocols, and establishment of a trace-and-track system for HIV-positive patients. Without swift action, the spread of HIV-AIDS may spiral out of control.

    Continue Reading

  • Bogdanovic ruled out of FIBA EuroBasket 2025

    Bogdanovic ruled out of FIBA EuroBasket 2025

    The official EuroBasket app

    RIGA (Latvia) – How much difference a day makes? Serbia were feeling fine about their chances after a clutch performance with Nikola Jokic going off for 39 points against the hosts Latvia on Saturday night, but Sunday morning started with devastating news.

    The Serbian Basketball Federation released a statement that Bogdan Bogdanovic would not be returning to action during the FIBA EuroBasket 2025.

    Bogdan Bogdanovic leaves the tournament after two games played

    Bogdan Bogdanovic leaves the tournament after two games played

    Bogdan Bogdanovic leaves the tournament after two games played

    Bogdan Bogdanovic leaves the tournament after two games played

    Bogdan Bogdanovic leaves the tournament after two games played

    📝

    Statement from the Serbian Basketball Federation

    The captain of the Serbian national team Bogdan Bogdanovic will not be playing for the rest of the FIBA EuroBasket after suffering an injury to his hamstring in the game against Portugal on Game Day 2 in the group phase.

    Bogdanovic has been diagnosed with a hamstring muscle tear which will keep him out of the rest of the championship. In agreement with Bogdan and his club, the Los Angeles Clippers, the captain will spend the next period going through intensive therapies in the United States to recover as fast as possible.

    The captain’s armband for the rest of the EuroBasket will be worn by Stefan Jovic.

    The Serbian national team will face Czechia in the next group phase game, on Monday at 21:15 local time, 20:15 CET.

    The Serbian National Federation wishes its captain a fast recovery.

    The 33-year-old suffered the injury during a fast break late in the first half in their game against Portugal. He immediately grabbed his hamstring and left the game, not returning in the second half.

    Bogdanovic has been the staple for Serbia ever since he made his FIBA EuroBasket debut back in 2013. He led the team to the Final in 2017, and also picked up two silver medals in the FIBA Basketball World Cup, in 2014 and 2019.

    Bogdan has also been a double digit scorer for Serbia in their two most recent Olympic podium hunts, winning silver in Rio de Janeiro in 2016, and bronze in Paris in 2024.

    Year

    Event

    Games

    Points

    Rebounds

    Assists

    2025

    EuroBasket

    2

    9.0

    3.5

    4.0

    2024

    Olympics

    6

    18.3

    4.0

    3.8

    2023

    World Cup

    8

    19.1

    3.3

    4.6

    2019

    World Cup

    8

    22.9

    4.1

    4.4

    2019

    World Cup Qualifiers

    2

    11

    2.5

    1

    2017

    EuroBasket

    9

    20.4

    3.4

    5.0

    2016

    Olympics

    8

    12.3

    3.6

    2.6

    2016

    OQT

    4

    17.8

    5.3

    6.0

    2015

    EuroBasket

    9

    8.9

    3.2

    3.2

    2014

    World Cup

    9

    12.0

    2.4

    2.6

    2013

    EuroBasket

    11

    9.4

    4.3

    2.0

    FIBA

    Continue Reading

  • AI stethoscope diagnoses heart disease in 15 seconds – Gulf News

    AI stethoscope diagnoses heart disease in 15 seconds – Gulf News

    1. AI stethoscope diagnoses heart disease in 15 seconds  Gulf News
    2. AI stethoscope could detect major heart conditions in seconds  BBC
    3. Doctors develop AI stethoscope that can detect major heart conditions in 15 seconds | Artificial intelligence (AI)  The Guardian
    4. NHS AI equipment to catch heart disease in 15 seconds  The Telegraph
    5. AI-powered stethoscope detects heart disease in just 15 seconds  The Times

    Continue Reading

  • AI spies questionable science journals, with some human help • The Register

    AI spies questionable science journals, with some human help • The Register

    About 1,000 of a set of 15,000 open access scientific journals appear to exist mainly to extract fees from naive academics.

    A trio of computer scientists from the University of Colorado Boulder, Syracuse University, and China’s Eastern Institute of Technology (EIT) arrived at this figure after building a machine learning classier to help identify “questionable” journals and then conducting a human review of the results – because AI falls short on its own.

    A questionable journal is one that violates best practices and has low editorial standards, existing mainly to coax academics into paying high fees to have their work appear in a publication that fails to provide expected editorial review.

    As detailed in a research paper published in Science Advances, “Estimating the predictability of questionable open-access journals,” scientific journals prior to the 1990s tended to be closed, available only through subscriptions paid for by institutions. 

    The open access movement changed that dynamic. It dates back to the 1990s, as the free software movement was gaining momentum, when researchers sought to expand the availability of academic research. One consequence of that transition, however, was that costs associated with peer-review and publication were shifted from subscribing organizations to authors.

    “The open access movement was set out to fix this lack of accessibility by changing the payment model,” the paper explains. “Open-access venues ask authors to pay directly rather than ask universities or libraries to subscribe, allowing scientists to retain their copyrights.”

    Open access scientific publishing is now widely accepted. For example, a 2022 memorandum from the White House Office of Science and Technology Policy directed US agencies to come up with a plan by the end of 2025 to make taxpayer-supported research publicly available.

    But the shift toward open access has led to the proliferation of dubious scientific publications. For more than a decade, researchers have been raising concerns about predatory and hijacked [PDF] journals. 

    The authors credit Jeffrey Beall, a librarian at the University of Colorado, with applying the term “predatory publishing” in 2009 to suspect journals that try to extract fees from authors without editorial review services. An archived version of Beall’s List of Potentially Predatory Journals and Publishers can still be found. The problem with a list-based approach is that scam journals can change their names and websites with ease.

    In light of these issues, Daniel Acuña (UC Boulder), Han Zhuang (EIT), and Lizheng Liang (Syracuse), set out to see whether an AI model might be able to help separate legitimate publications from the questionable ones using detectable characteristics (e.g. authors that frequently cite their own work).

    “Science progresses through relying on the work of others,” Acuña told The Register in an email. “Bad science is polluting the scientific landscape with unusable findings. Questionable journals publish almost anything and therefore the science they have is unreliable. 

    “What I hope to accomplish is to help get rid of this bad science by proactively helping flagging suspected journals so that professionals (who are scarce) can focus their efforts on what’s most important.”

    Acuña is also the founder of ReviewerZero AI, a service that employs AI to detect research integrity problems.

    Winnowing down a data set of nearly 200,000 open access journals, the three computer scientists settled on a set of 15,191 of them.

    They trained a classifier model to identify dubious journals and when they ran it on the set of 15,191, the model flagged 1,437 titles. But the model missed the mark about a quarter of the time, based on subsequent human review.

    “About 1,092 are expected to be genuinely questionable, ~345 are false positives (24 percent of the flagged set), and ~1,782 problematic journals would remain undetected (false negatives),” the paper says.

    “At a broader level, our technique can be adapted,” said Acuña. “If we care a lot about false positives, we can flag more stringently.” He pointed to a passage in the paper that says under a more stringent setting, only five false alarms out of 240 would be expected.

    Acuña added that while many AI applications today aim for full automation, “for such delicate matters as the one we are examining here, the AI is not there yet, but it helps a lot.”

    The authors are not yet ready to name and shame the dubious journals – doing so could invite a legal challenge.

    “We hope to collaborate with indexing services and assist reputable publishers who may be concerned about the degradation of their journals,” said Acuña. “We could make it available in the near future to scientists before they submit to a journal.” ®

    Continue Reading

  • 33 killed, 7 lakh evacuated: Pakistan’s Punjab faces biggest flood in history; over 2 million affected

    33 killed, 7 lakh evacuated: Pakistan’s Punjab faces biggest flood in history; over 2 million affected

    Villagers with their livestock navigate through a flooded area after torrential rains and rising water level in the rivers, in Pindi Bhattian, Pakistan, Sunday, Aug. 31, 2025. (AP)

    Monsoon rains continue to cause severe flooding in Pakistan’s Punjab province, which is facing the biggest flood in its history, Associated Press reported.Experts say global warming has made this year’s monsoon worse in Pakistan, which is highly exposed to climate change. In recent months, heavy rains and cloudbursts have led to flash floods and landslides in the northern and northwestern mountains.According to ARY News, cited by ANI, flooding and rains have killed 33 people, hit 2,200 villages, and forced over 700,000 residents to evacuate in Pakistan’s Punjab province.Punjab’s senior minister Maryam Aurangzeb said at a press conference on Sunday: “This is the biggest flood in the history of the Punjab. The flood has affected two million people. It’s the first time that the three rivers — Sutlej, Chenab, and Ravi — have carried such high levels of water.”Punjab, with about 150 million people, is a key farming area and Pakistan’s main wheat producer. Floods in 2022 destroyed large areas of crops in the east and south, prompting Prime Minister Shehbaz Sharif to warn of food shortages.The national weather center reported that Punjab received 26.5% more monsoon rainfall between July 1 and August 27 compared with the same period last year.Pakistan’s disaster management authority said that since June 26, rain-related incidents have killed 849 people and injured 1,130 across the country.


    Continue Reading

  • 5 shocking facts about the gas giant bigger than all planets combined

    5 shocking facts about the gas giant bigger than all planets combined

    Despite centuries of study, Jupiter still hides its deepest secrets. It has no solid surface, only layers of dense gas and possibly a core of rock or metallic hydrogen under immense pressure. Recent missions, particularly NASA’s Juno spacecraft, have revealed that Jupiter’s atmosphere is far more complex than previously thought, with ammonia storms, jet streams running thousands of kilometres deep, and strange ‘cyclone clusters’ circling its poles.

    Continue Reading

  • Septic Shock After Surgery in Arnold-Chiari Malformation Type I: A Cas

    Septic Shock After Surgery in Arnold-Chiari Malformation Type I: A Cas

    Background

    Arnold-Chiari Malformation Type I (ACM-I) is a congenital neurological disorder characterized by the downward displacement of cerebellar tonsils through the foramen magnum, leading to cerebrospinal fluid (CSF) flow obstruction and subsequent neurological deficits.1 While decompression surgery is the standard treatment for symptomatic ACM-I, it carries significant postoperative risks, particularly CSF leakage and infectious complications, which can result in life-threatening conditions such as septic shock.2

    One of the critical concerns in postoperative care for ACM-I patients is early recognition and management of complications, particularly in individuals with underlying conditions that may impair immune response.3 Patients with rheumatoid arthritis (RA), such as the case presented here, are inherently at a higher risk for infections due to chronic inflammation and immunosuppressive therapies (eg, corticosteroids and methotrexate).4 These factors can complicate postoperative healing and increase susceptibility to severe infections, making meticulous monitoring in the intensive care unit (ICU) essential.

    This case report discusses the rapid progression from CSF leakage to septic shock in an ACM-I patient, emphasizing the importance of timely microbiological assessment, aggressive infection control, and individualized antibiotic therapy in critical care settings. By examining the challenges encountered in managing this patient, we aim to provide insights into improving postoperative surveillance and early intervention strategies in neurosurgical patients at high risk of sepsis.

    Case Presentation

    The patient is a 45-year-old married woman with a known history of rheumatoid arthritis for about ten years, which was being managed with medication. She reported no other medical conditions in her medical history. In terms of medication, she had been taking NSAIDs such as ibuprofen and naproxen to manage her pain. At times, under her physician’s guidance, she also took methylprednisolone and methotrexate periodically to control her condition. Recently, she presented to medical facilities with complaints of neck pain radiating to her arms, along with numbness and weakness in the upper limbs. These symptoms had started about a year prior and had intensified in recent months, not responding to prior treatments. During physical examinations, the patient showed muscle weakness in the upper limbs but had no other symptoms, such as gait disturbance, imbalance, headache, or dizziness. In neurological examinations, muscle strength was recorded as 3–4 out of 5 in the right upper limb, 2–3 out of 5 in the left upper limb, and 5 out of 5 in both lower limbs. Initial head and neck X-Ray was obtained (Figure 1).

    Figure 1 Radiograph of the cervical spine (A) Flexion lateral view and (B) Extension lateral view (C) anterior-posterior view. The cervical vertebrae are normal and free of fractures and dislocations.

    A brain MRI of the patient (shown in Figure 2) was used for further evaluation and differential diagnosis. Based on the image, the extent of tonsillar herniation is estimated to be approximately 8 to 10 millimeters below the foramen magnum, which is consistent with the diagnostic criteria for Chiari Malformation Type I (defined as herniation greater than 5 millimeters).

    Figure 2 MRI of the brain without contrast of Arnold-Chiari malformation I. The sagittal view demonstrates the herniated cerebellar tonsils descending below the level of the foramen magnum.

    Based on imaging results, a diagnosis of ACM-I was made. Following this diagnosis, the patient underwent posterior fossa decompression surgery, which included decompressive craniectomy, resection of the foramen magnum, C1 laminectomy, V-shaped durotomy, coagulation of the tonsils, and duraplasty. Part of the timeline of events changes is provided in Table 1.

    Table 1 Timeline of Events and Daily Vital Signs of the Patient During the Hospitalization

    After surgery, she was transferred to the intensive care unit for continued treatment. In addition to postoperative supportive care, she was started on antibiotics: ceftazidime 2 grams every 8 hours and vancomycin 1 gram every 12 hours. According to the neurosurgery team’s recommendations, the patient’s head was maintained in an elevated position during the ICU stay to facilitate venous drainage and minimize the risk of cerebrospinal fluid (CSF) leakage. In addition, lactulose syrup was prescribed as a stool softener to prevent constipation and reduce the likelihood of excessive straining during defecation, thereby minimizing sudden increases in intra-abdominal and intracranial pressures.

    On the sixth day of hospitalization, CSF leakage was observed at the surgical site, and the patient developed a fever. Despite receiving broad-spectrum antibiotic treatment, her condition worsened by the sixth day, with a significant increase in white blood cell count (WBC: 15,800). At this point, ceftazidime was discontinued, and meropenem 1 gram every 8 hours was started to control the infection. However, despite these adjustments, her WBC count reached 38,600 by the eleventh day. Part of the timeline of laboratory changes is provided in Table 2.

    Table 2 A Timeline of Some of the Patient’s Laboratory Changes

    After the laboratory changes, the patient’s hemodynamic status became unstable, leading to the need for intubation to provide cardiopulmonary support. On the ninth day, the patient was taken back to the operating room for extensive debridement and washing of the surgical site. Additionally, CSF culture results indicated infection with Acinetobacter baumannii, which is sensitive to colistin. Based on the CSF culture report, infectious disease, and clinical pharmacology consultations were carried out. Following these consultations, the patient’s previous antibiotics were discontinued, and broad-spectrum antibiotics were started, including intravenous and intrathecal colistin and intravenous ampicillin-sulbactam 3 grams every 6 hours. Due to the positive Candida culture from the urinary catheter, the patient’s Foley catheter was replaced. On day 7 of hospitalization, the patient developed septic shock with persistent hypotension (BP 85/55 mmHg, HR 118 bpm, SpO2 90%). Norepinephrine infusion was started at 0.1 μg/kg/min and was gradually titrated to 0.5 μg/kg/min by day 9 in an effort to maintain MAP ≥65 mmHg. However, the patient’s condition remained unstable despite maximal vasopressor support. Additionally, the antifungal drug caspofungin 75 mg was administered as a bolus and gradually increased to 50 mg daily. Despite maximal supportive care in the intensive care unit, including broad-spectrum antibiotics and high-dose norepinephrine infusion, the patient’s condition deteriorated and she ultimately died on hospital day 11 due to refractory septic shock.

    Discussion and Conclusion

    This case underscores the importance of proper and timely management of postoperative complications in patients with ACM-I. Although posterior fossa decompression surgery is considered the standard treatment for these patients and can lead to symptom improvement, complications such as CSF leakage and severe infections can result in adverse outcomes. In this case, despite aggressive medical and supportive management in the intensive care unit, the patient’s condition rapidly deteriorated, ultimately leading to death from refractory septic shock.

    A review of the medical literature reveals that ACM-I, particularly after posterior fossa decompression surgery, can be associated with postoperative complications such as meningitis, abscess, and septic shock. For instance, the results of our study are in significant agreement with previous research findings. A survey by Passias et al5 showed that patients with ACM-I who underwent surgery faced substantial risks, including postoperative complications such as neurological issues, anemia, and respiratory distress. This study also indicated that patients who underwent spinal fusion, particularly those with fusion levels of four or more, had a significantly higher incidence of complications. These findings align with the results of our study, as our patient also experienced severe complications after surgery. This study emphasizes the importance of postoperative care and careful monitoring of patient’s conditions.

    Additionally, the results of other studies have shown that comorbidities such as cardiovascular, pulmonary, renal diseases, and malignancies can increase the risk of postoperative complications in these patients.5–7 In our study, underlying rheumatoid arthritis and other potential predisposing factors may have contributed to the increased surgical risk. Therefore, it is recommended that future studies examine the impact of underlying conditions on surgical outcomes. This highlights the importance of comprehensive patient evaluation and management of these conditions before surgery, which can help reduce postoperative complications.

    Meticulous attention to the quality of dural closure is a critical step in preventing postoperative cerebrospinal fluid (CSF) leakage and its potentially severe complications, such as meningitis and septic shock. To minimize the risk of postoperative CSF leakage following posterior fossa decompression, several surgical and postoperative strategies have been recommended in the literature. These include performing an intraoperative Valsalva maneuver to identify occult dural tears, avoiding full-thickness dural coagulation to preserve dural integrity, meticulous multilayer dural closure with watertight suturing techniques, and the use of graft augmentation when necessary.2 Postoperatively, maintaining appropriate head elevation, minimizing excessive straining or coughing, and close monitoring for early signs of leakage are essential preventive measures. Considering our patient’s background of rheumatoid arthritis and a history of long-term corticosteroid use, which can impair wound healing, such precautions are particularly important.2,8

    In another study by Alexander et al,9 the relationship between ACM-I and severe infections post-surgery is established. The results of this study align with our findings. In the case of our patient, despite appropriate treatment measures, she developed postoperative complications, including septic shock, which is consistent with the findings reported in the literature.10 This comparison highlights that even when the best treatment practices are applied, ACM-I can lead to severe and life-threatening complications. These findings emphasize the need for careful monitoring and continuous follow-up of patients after surgery and the importance of effective infection management.

    Therefore, the results of previous studies have also shown that postoperative complications in patients with ACM-I are rare but potentially dangerous.11 This case highlights the importance of heightened vigilance in postoperative care and the need for close monitoring of patients’ status, especially in cases of CSF leakage and early signs of infection.12,13 Additionally, there is a need for further research to explore more effective strategies for preventing and managing these complications.

    In this case, the approach taken to manage and treat ACM-I and septic shock post-surgery was significant in several respects. First, the accurate and early diagnosis of Chiari malformation using appropriate imaging techniques was a strength in managing this case, which led to the correct decision for posterior fossa decompression surgery. Additionally, broad-spectrum antibiotics in managing postoperative infection, although they ultimately could not prevent the fatal septic shock, demonstrated the correct approach to infection control. Limitations of this case include the failure to prevent CSF leakage and the lack of timely infection control, both of which contributed to the patient’s deteriorating condition.

    The conclusion of this evidence-based study is derived from the patient’s condition and their response to the treatments provided. The decision for decompressive surgery was made due to the severity of the patient’s symptoms and confirmation of the diagnosis through imaging. Although appropriate therapeutic measures were implemented, CSF leakage and subsequent infection led to septic shock and, ultimately, the patient’s death. These results indicate that even with proper management, the prognosis for patients with ACM-I can be challenging.

    This case emphasizes the importance of precise management and continuous monitoring of patients after surgery for ACM-I. Previous studies have recommended thorough clinical examinations in the postoperative period to diagnose the most common complications, including aseptic meningitis, CSF leakage, infections, and hydrocephalus.14,15 Therefore, specialized care to prevent infections and manage postoperative complications is essential. This study also highlights that awareness of the potential for septic shock and its early prediction can play a significant role in reducing mortality associated with this complication. As a result, more precise planning for preventing and managing postoperative complications can lead to better therapeutic outcomes.

    Abbreviations

    ACM-I, Arnold-Chiari Malformation Type I; CSF, Cerebrospinal fluid; ICU, Intensive Care Unit; CBC, Complete Blood Count; WBC, White Blood Count; RBC, Red Blood Cell; LDH, Lactate Dehydrogenase; B/C, Blood Culture Test; U/C, Urine Culture; CRP, C-reactive protein.

    Data Sharing Statement

    The data supporting this study’s findings are available from the corresponding author upon reasonable request.

    Ethics Approval

    This study was conducted under the principles outlined in the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of Tabriz University of Medical Sciences, with approval number (IR.TBZMED.REC.1402.840). According to institutional policies, this approval covers the entire research process, including the preparation and publication of case reports. Therefore, no additional institutional approval was required for publication.

    Consent for Publication

    The present study was conducted in one of the educational and medical centers in Iran. In these centers, during hospitalization, informed consent is obtained from all patients for the participation of students from different disciplines in the treatment processes of these patients and the use of their clinical records for education and research. In this study, written informed consent was obtained from the patient and his family for the use of their personal and clinical information in this case report, and it was ensured that confidentiality and anonymity were maintained. Since the patient unfortunately died during hospitalization, due to the importance of the issue, informed consent was obtained again from the patient’s family for its preparation, reporting, and possible publication.

    Acknowledgments

    We would like to express our sincere appreciation to the Clinical Research Development Unit, Imam Reza General Hospital, Tabriz, Iran, for their valuable cooperation and support in conducting this research. Additionally, we extend our heartfelt gratitude to all the staff of the intensive care unit for their dedicated assistance and contributions throughout the study.

    Author Contributions

    All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

    Funding

    This study was funded by Tabriz University of Medical Sciences Faculty of Medicine.

    Disclosure

    The authors declare that they have no competing interests in this work.

    References

    1. Adkhamjanovich NA. Clinical and neurological manifestations of Arnold-Chiari malformation. Progress Sci. 2024;1(1):5023–5512.

    2. Costa F, Ait Benali S, Dantas F, et al. Chiari malformation: diagnosis, classifications, natural history, and conservative management. World Federation of Neurosurgical Societies Spine Committee Recommendations. Spine. 2025;50(11):767–778. PMID: 39925305. doi:10.1097/BRS.0000000000005289

    3. Hamal D, Fernandes A, Ghimire P, Wong A. Acute respiratory failure requiring invasive ventilation in adults with congenital syringomyelia/Arnold-Chiari malformations: a systematic review. Cureus. 2024;16(9):e70109. PMID: 39318661; PMCID: PMC11421830. doi:10.7759/cureus.70109

    4. Riley TR, George MD. Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis. RMD Open. 2021;7(1):e001235. PMID: 33597206; PMCID: PMC7893655. doi:10.1136/rmdopen-2020-001235

    5. Passias PG, Naessig S, Para A, et al. Complication rates following Chiari malformation surgical management for Arnold-Chiari type I based on surgical variables: a national perspective. J Craniovertebr Junction Spine. 2020;11(3):169–172. PMID: 33100765; PMCID: PMC7546047. doi:10.4103/jcvjs.JCVJS_69_20

    6. Kelly MP, Guillaume TJ, Lenke LG. Spinal DEFORMITY ASSOciated with Chiari malformation. Neurosurg Clin N Am. 2015;26(4):579–585. PMID: 26408068; PMCID: PMC4584090. doi:10.1016/j.nec.2015.06.005

    7. Spina A, Mortini P. The dark side of Chiari malformation. World Neurosurg. 2023;172:43–45. PMID: 36746237. doi:10.1016/j.wneu.2023.01.112

    8. Wang L, Lei D, Tang N, et al. Updates on Surgical Strategies for Adult Chiari Malformation Type I: a Review. Neurosurg Subspecialties. 2025;1(1):28–38. doi:10.14218/NSSS.2024.00006

    9. Alexander H, Tsering D, Myseros JS, et al. Management of Chiari I malformations: a paradigm in evolution. Childs Nerv Syst. 2019;35(10):1809–1826. PMID: 31352576. doi:10.1007/s00381-019-04265-2

    10. Tominaga H, Setoguchi T, Ishidou Y, Nagano S, Yamamoto T, Komiya S. Risk factors for surgical site infection and urinary tract infection after spine surgery. Eur Spine J. 2016;25(12):3908–3915. PMID: 27349753. doi:10.1007/s00586-016-4674-2

    11. Ciaramitaro P, Massimi L, Bertuccio A, et al. International Experts Jury of the Chiari Syringomyelia Consensus Conference, Milan, November 11–13, 2019. Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document. Neurol Sci. 2022;43(2):1327–1342. Erratum in: Neurol Sci. 2022 Feb;43(2):1483–1484. doi: 10.1007/s10072-021-05724-y. PMID: 34129128. doi:10.1007/s10072-021-05347-3

    12. Kumar R, Cutsforth-Gregory JK, Brinjikji W. Cerebrospinal fluid leaks, spontaneous intracranial hypotension, and Chiari I malformation. Neurosurg Clin N Am. 2023;34(1):185–192. PMID: 36424060. doi:10.1016/j.nec.2022.08.012

    13. Xing QQ, Miao M, Zhang QW, Wu Y, He FF. Gorham-Stout disease affecting the spine with cerebrospinal fluid leakage and Chiari-like tonsillar herniation: a rare case report and review of literature. BMC Neurol. 2023;23(1):59. PMID: 36737721; PMCID: PMC9896703. doi:10.1186/s12883-023-03092-y

    14. Giammattei L, Borsotti F, Parker F, Messerer M. Chiari I malformation: surgical technique, indications and limits. Acta Neurochir. 2018;160(1):213–217. PMID: 29130121. doi:10.1007/s00701-017-3380-0

    15. Zhao JL, Li MH, Wang CL, Meng W. A systematic review of Chiari I malformation: techniques and outcomes. World Neurosurg. 2016;88:7–14. PMID: 26732952. doi:10.1016/j.wneu.2015.11.087

    Continue Reading

  • President Zardari gives assent to anti-terrorism amendment bill

    President Zardari gives assent to anti-terrorism amendment bill

    President Asif Ali Zardari signs a bill at the Aiwan-e-Sadr in Islamabad, on July 23, 2024. — APP
    • Anti-terrorism bill was passed by NA, Senate this month.
    • Law empowers LEAs to detain individuals up to 3 months
    • “Law to ensure transparency, accountability in detentions”.

    ISLAMABAD: President Asif Ali Zardari on Sunday accorded his assent to the Anti-Terrorism (Amendment) Bill, 2025, according to a statement issued by the President’s House.

    The bill, which seeks to improve counterterrorism efforts while ensuring legal oversight and safeguards, was passed by both the lower and upper houses of parliament — the National Assembly and the Senate — this month.

    “The law is designed to ensure transparency and accountability in detentions, with a built-in three-year sunset clause to limit its duration,” it said.

    “The law includes judicial oversight and safeguards to provide recourse against misuse and abuse of power, unlike past arbitrary practices,” the statement read.

    “The amendment aimed to improve counter-terrorism efforts while ensuring legal oversight and safeguards… This is an important step in addressing Pakistan’s ongoing security challenges,” it further stated.

    The statement of objects and reasons, tabled during the bill’s passage in Parliament, noted that the prevailing security challenges in the country demanded a “robust response beyond the scope of existing laws.”

    This provision would allow for the preventative detention of suspects based on credible information or reasonable suspicion, thereby disrupting terrorist plots before they can be executed, the statement said.

    This will also provide LEAs with the legal backing to conduct more effective operations against terrorism. It would facilitate the use of Joint Interrogation Teams (JITs), composed of members from various law enforcement and intelligence agencies, to conduct comprehensive inquiries and gather actionable intelligence, it added.

    The bill states that any individual suspected of activities threatening national security or public safety may be detained. It further allows for the detention of individuals involved in target killings, kidnapping for ransom, or extortion for a period of up to three months.


    Continue Reading

  • FDA Grants Breakthrough Device Designation to Haystack MRD ctDNA Liquid Biopsy for Stage II CRC

    FDA Grants Breakthrough Device Designation to Haystack MRD ctDNA Liquid Biopsy for Stage II CRC

    The FDA has granted breakthrough device designation for the Haystack MRD® test, a circulating tumor DNA (ctDNA) liquid biopsy, designed to identify patients with stage II colorectal cancer (CRC) who are minimal residual disease (MRD) positive and may benefit from adjuvant therapy following curative-intent surgery.1

    The Haystack MRD test is intended to detect MRD by uncovering trace fragments of tumor-derived DNA circulating in the bloodstream. These fragments can indicate residual, recurrent, or treatment-resistant disease, enabling clinicians to identify patients who are ctDNA-positive after surgery and guide adjuvant treatment decisions in accordance with approved product labeling.

    Developed by leaders in cancer genomics and liquid biopsy innovation, Haystack MRD is a highly sensitive and specific assay optimized for detecting very low levels of ctDNA. Its clinical utility has been demonstrated in multiple trials and research collaborations with major institutions across the United States, Canada, and Australia, including the pivotal phase 2 DYNAMIC study (ACTRN12615000381583).2 The test is already being used by clinicians at more than 75 leading cancer centers, academic institutions, and health systems as a part of multiple clinical trials and research studies.1

    “We are committed to working with the FDA and our research partners to validate the use of Haystack MRD in a variety of solid tumors, building on this first designation for an early-stage CRC,” Dan Edelstein, vice president and general manager of Haystack Oncology, stated in a news release. “Our goal is to deliver highly accurate, personalized monitoring of treatment response and recurrence to more patients, both in clinical care and in pharmaceutical trials, and this breakthrough designation brings us closer to our goal.”

    DYNAMIC Study Breakdown

    The study enrolled 455 patients with stage II colon cancer who were randomized in a 2:1 ratio to either a ctDNA-guided strategy (n = 302) or standard clinicopathological assessment (n = 153).2 In the ctDNA-guided arm, adjuvant therapy decisions were based exclusively on ctDNA testing performed on blood samples collected at 4 and 7 weeks after surgery. Patients with detectable ctDNA at either time point were treated with adjuvant therapy, and those with undetectable ctDNA did not receive systemic therapy.

    In the standard-of-care arm, treatment allocation followed conventional clinicopathological risk factors, including tumor size, grade, and lymph node assessment. Patients deemed high risk received adjuvant treatment. This design allowed direct comparison between biomarker-driven and traditional approaches to post-surgical therapy selection.

    This pivotal trial demonstrated that chemotherapy use was significantly reduced in the ctDNA-guided group at 15% compared with 28% in the standard-of-care group. Importantly, this reduction in systemic therapy exposure did not compromise efficacy: 2-year recurrence-free survival (RFS) was comparable between both strategies.

    Plans for Future Analysis

    In stage III CRC, adjuvant therapy is standard for nearly all patients; however, the intensity and duration of treatment often rely on clinicopathologic features, which may lead to over- or under-treatment. The ongoing phase 2/3 DYNAMIC-III trial (ACTRN12617001566325) is evaluating whether ctDNA can refine treatment intensity by identifying patients who may benefit from de-escalation strategies and those who may require escalation.3 Patients with resected stage III colon cancer who are fit for adjuvant chemotherapy are being randomly to receive ctDNA-informed treatment guidance vs standard-of-care management. In the ctDNA arm, patients with a positive ctDNA test 5 or 6 weeks after surgery are receiving escalated therapy; rather than single-agent fluoropyrimidine or an oxaliplatin-based doublet, patients are being escalated from 3 months of the doublet to 6 months or FOLFOXIRI, or from 6 months of the doublet to FOLFOXIRI.

    In ovarian cancer, where diagnosis frequently occurs at advanced stages, ctDNA is being studied as a dynamic prognostic marker in the DYNAMIC-ovarian trial.1 Investigators are assessing ctDNA at multiple time points—including prior to therapy initiation, during treatment, and after completion of therapy—in both neoadjuvant and adjuvant settings. This study may clarify whether ctDNA can serve as an early indicator of treatment response and long-term outcomes in this aggressive malignancy.

    References

    1. FDA grants breakthrough device designation for haystack mrd circulating tumor dna test from quest diagnostics. News Release. Accessed August 29, 2025. https://www.prnewswire.com/news-releases/fda-grants-breakthrough-device-designation-for-haystack-mrd-circulating-tumor-dna-test-from-quest-diagnostics-302536229.html
    2. W K. Haystack MRDTM: Proven clinical utility – Haystack MRDTM. Haystack MRDTM. Published May 31, 2023. Accessed August 29, 2025. https://haystackmrd.com/haystack-mrd-proven-clinical-utility/
    3. Tie J, Wang Y, Loree JM, et al. Cohen ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: Primary analysis of the ctDNA-positive cohort from the randomized AGITG dynamic-III trial (intergroup study of AGITG and CCTG). J Clin Oncol. 2025;43(suppl 16):3503. doi:10.1200/JCO.2025.43.16_suppl.3503

    Continue Reading